Jonsson Comprehensive Cancer Center

This study tests whether a special MRI technique (CEST) can help surgeons remove more glioblastoma tissue during surgery. Standard surgery only removes parts of the tumor that show up on regular MRI, but this new method may reveal hidden tumor areas. The trial will compare how lo…

This study tests a drug called ropeginterferon alfa-2b in 35 adults with rare blood cancers like chronic myelomonocytic leukemia (CMML) and related overlap syndromes. The drug is a lab-made version of a natural immune protein that helps slow cancer cell growth. The goal is to fin…

This study tests whether giving the drug zipalertinib together with standard chemotherapy before surgery can shrink tumors in people with a specific type of lung cancer (EGFR-mutant non-small cell lung cancer). About 16 adults with stage II to IIIB cancer that can be surgically r…

This study tests two drugs, imlunestrant and abemaciclib, in people with ER+ breast cancer who have small amounts of tumor DNA still in their blood after initial treatment. The goal is to see if this combination can clear those remaining cancer traces and prevent the cancer from …

This study tests a small, portable wound vacuum (SNaP device) to see if it helps surgical wounds on the lower leg heal faster after Mohs surgery for skin cancer. About 60 adults aged 19-79 will either use the device or receive standard care. The goal is to compare healing times a…

This study tests a personalized, supervised exercise program done at home to help people who finished treatment for gastroesophageal cancer. The goal is to see if it's possible and helpful for improving physical function. About 20 adults who completed cancer therapy within the pa…

This study looks at how chemotherapy for early-stage gastroesophageal cancer changes a person's physical abilities over time. Researchers will follow 72 adults before, during, and after treatment to measure strength, balance, and walking speed. The goal is to better understand th…